Boy in Minnesota survives fall that sent arrow through his brain: ‘It's a miracle'
Abby Deterding recently told the Minneapolis news station KARE 'it's a miracle' that the freak mishap did not kill her son, Gus. 'We're just thankful, so grateful,' she said.
As his parents recount it, Gus was helping his father, Dave, pack up his truck for a hunting trip in March when he slipped on the icy driveway outside their home in Alexandria, about 130 miles north-west of Minneapolis.
A youth bow and arrow were among the items Gus was carrying at the time he slipped. And he fell face-first on the arrow, which penetrated his head just to the right of his nose.
Gus pulled the arrow out of his head by himself and immediately went to see his mother, who was vacuuming inside, KARE reported. He evidently was not bleeding much but was panicked.
'He kept saying, 'Mom, am I dying? Am I going to leave you? I don't want to leave you yet,'' Abby Deterding recalled her son saying. She said she told Gus he would be OK and they were just going to the hospital to get some stitches.
A cautious emergency room doctor had Gus flown by helicopter to Children's Minnesota hospital in Minneapolis, where staffers observed him a few hours before releasing him home. But, after getting home, Gus began vomiting, and his parents brought him back to the hospital, which took head scans of the boy.
The scans contained a startling revelation, as KARE noted: the arrow had pierced through the middle of Gus's brain and came within less than an inch of exiting his skull.
'It literally took my breath away, and I felt sick to my stomach,' Abby Deterding said to the outlet about what it felt like for her to see those scans. 'I couldn't believe it.'
She said she remembered thinking: 'No, that far, what?''
Adding to the confusion was the fact that Gus seemed to be fine while in a hospital bed nearby.
The medical director of the Children's Minnesota's pediatric intensive care unit, Dr Ken Maslonka, reportedly said to KARE that he had 'never seen anything like this' in his 28-year career.
'He looked too normal,' Maslonka said.
Maslonka told the outlet that he had created a model meant to show the trajectory of the arrow that went into Gus's head. Had he seen his model without already knowing the outcome, Maslonka said he would have assumed the injury depicted was fatal.
Gus, though, was showing no ill effects from the wound a few months after it had occurred, prompting Maslonka to attribute that to either 'fortune' or 'God controlling the direction of that arrow'.
Abby and Dave Deterding said it was their opinion that Gus's survival was miraculous rather than lucky.
'We know,' Dave Deterding said, 'it didn't just happen.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
11 minutes ago
- Daily Mail
Experts pinpoint reason for huge surge in cases of bowel and colon cancer - and twelve other types
Rising obesity levels have led to a tripling of deaths from cancers linked to being overweight, American medics warn. Analysing data from 33,000 obesity related cancer deaths in the US between the late 90s and 2020 the experts found the number of fatalities had risen from 3.7 per million to 13.5 per million across the two decades. This included deaths from bowel and colon cancer, a form of the disease known to be mysteriously rising among young healthy adults under 50. The analysis also found certain parts of the population had been harder hit by rising cancer deaths than others. These included women, older adults, rural population and people from Black and Native American backgrounds. Obesity is known to increase the risk of 13 types of cancer, with being overweight the second biggest cause of the disease in Britain triggering one in 20 cases. In the US, cancers linked to obesity account for 40 per cent of all forms of the disease diagnosed per annum. Dr Faizan Ahmed, of Hackensack Meridian Jersey Shore University Medical Centre in New Jersey and lead researcher of the analysis, said the findings showed the importance of public measures to tackle obesity. 'This research underscores the need for targeted public health strategies such as early screening and improved access to care, especially in high-risk rural and underserved areas,' he said. The analysis also found the burden of obesity-related cancer deaths was higher in certain parts of the US. Regionally the Midwest had the highest rates while the Northeast had the lowest. By state level Vermont, Minnesota and Oklahoma had the highest rates of deaths, while Utah, Alabama and Virginia had the lowest. Obesity increases the risk of 13 cancers: oesophageal, breast, bowel, uterus, gallbladder, stomach, kidneys, liver, ovaries, pancreas, the thyroid and one type of brain and blood cancer respectively. Having extra fat on the body increases the risk of cancer in various ways. Too much body fat can cause levels of growth hormones to increase. This in turn encourages cells to divide more often, and the risk of mutations that could become cancer. Fat also causes inflammation in the body where it accumulates which also encourages cell division and increases the risk of cancer. Finally—for women—fat cells can produce more of the female sex hormone oestrogen after menopause. This can lead to increased cell division in the breasts and womb, increasing the risk of cancer developing. About one in four people in England are obese, roughly double the proportion in the 90s. The increase has been even starker in the US with 40 per cent now considered obese compared to about 12 per cent in the early 90s. While obesity is thought to be responsible for about 5 per cent of all cancers in the UK, this dramatically increases for certain types. For bowel cancer—which includes colon and rectal cancer—obesity or being overweight triggers 11 per cent of all cases of this disease. Men are especially at risk with research suggesting a man's risk of developing bowel cancer increases by 10 per cent for every 11lbs (5kg) he puts on in adulthood. The risk of colon cancer in men increases by 30 per cent for every five increase of their body mass index (BMI). For women the chances of developing colon cancer increases by 12 per cent for every five BMI they gain. Experts have noted a concerning and mysterious rise in rates of bowel cancer among young adults, defined in cancer terms as those under 50. A recent global study found rates of bowel cancer in under 50 year-olds are rising in 27 of 50 nations. England is averaging a 3.6 per cent rise in younger adults every year-one of the highest increases recorded. While the disease is known linked to obesity, experts have noted that the disease also seems to also be occurring in fit and healthy patients. Some experts believe the explanation must lie in environmental factors young people have been exposed to more than previous generations. While no 'smoking gun' has been found, there are multiple theories. These include modern chemicals in diets, microplastics, pollution, and one recent study even pinned the surge on exposure to E. coli in food. There are around 2,600 new bowel cancer cases in people aged 25-49 in Britain every year, and around 44,100 new cases among all ages. Around 44,000 cases of bowel cancer are diagnosed every year in the UK, with about 130,000 in the US. The disease kills almost 17,000 Britons each year, with the death toll rising to about 50,000 in America. Overall, just over half of bowel cancer patients are expected to be alive 10 years after their diagnosis. The health burden of obesity— which costs the UK economy billions —is one of the reasons why ministers are so keen to rollout revolutionary new weight loss jabs. Sold under the brands Mounjaro Wegovy, increasing access to these drugs is one of one the cornerstones of the 10-year-plan for the NHS. The analysis on US obesity-linked cancer deaths was presented at the ENDO 2025, the Endocrine Society's annual meeting in San Francisco and has not been fully published.
Daily Mail
13 minutes ago
- Daily Mail
Scientists discover new link between Mounjaro and BREAST cancer
Mounjaro could help slash the risk of breast cancer tumours developing, exciting new research has suggested. The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health benefits, such as reducing the risk of heart attacks, strokes and kidney disease. Now, scientists have discovered that tirzepatide—the ingredient behind Mounjaro—may 'significantly' slow the growth of breast cancer tumours. American scientists, who carried out the trial, said the findings on mice show the drugs have a 'beneficial impact' on women with the disease. However, they cautioned further research was necessary to confirm their findings. Researchers also didn't speculate why the drug, which belong to class of medications called GLP-1 agonists, might lower a patient's chances of cancer. It comes as breakthrough research in May revealed that GLP-1s could help ward off up to 14 types of cancer including breast. Studies have also suggested obesity is a major risk factor in breast cancer returning and weight loss could improve outcomes. The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health benefits, such as slashing the risk of heart attacks, strokes and kidney disease Amanda Kucinskas, a research fellow in obesity and breast cancer risk at the University of Michigan and study author, said: 'While it is very preliminary data, our studies in mice suggest that these new anti-obesity drugs may be a way to reduce obesity-associated breast cancer risk or improve outcomes. 'While these are very preliminary results, they suggest that this new anti-obesity drug may also have a beneficial impact on breast cancer outcomes,' In the study, researchers tracked 16 nine-week-old mice with breast cancer tumours who were fed a high-fat diet to induce obesity. At 32 weeks old—roughly middle age for a mouse—the obese animals were divided into two groups. One group received tirzepatide injections every other day for 16 weeks, and the other a placebo. Scientists then measured the mice's weight and tumour growth twice a week. They found mice on the medication lost around a fifth of their body weight—roughly the average weight lost by patients taking Mounjaro long term. The fat loss occurred mainly in adipose tissue, the body's fat-storing cells. Mice treated with tirzepatide also had significantly smaller tumors, the scientists said. There was a 'clear link' between lower body weight and smaller tumor size, while total fat mass was also 'strongly linked' to how large the tumors became, they added. However, they cautioned that exactly how tirzepatide slowed tumour growth was not yet understood and further tests, including in humans, would first be necessary. The findings were presented in full this week at ENDO 2025, the Endocrine Society's annual meeting in San Francisco. It comes as research presented at the American Society for Clinical Oncology (ASCO) annual conference in May suggested GLP-1s could slash the risk of 14 obesity-related cancer—including breast—for people with diabetes. US scientists found those on GLP-1s had a 7 per cent lower risk of developing an obesity-related cancer than patients on DDP-4 inhibitors, another diabetes medication. When other health benefits were factored in, these patients were also 8 per cent less likely to die over the 10-year period. In December, groundbreaking research presented at the San Antonio Breast Cancer Symposium also suggested the jabs could also help protect against breast cancer returning. One study of more than 1,000 patients by the University of Texas found obese patients who took the drugs for just over a year after finishing treatment on average had a 'significantly improved' chance of living longer. However, surprisingly, they also found patients taking hormone drugs such as tamoxifen—given to many women to stop breast cancer recurrence—gained weight, despite using the jabs. At the time, experts told MailOnline they were unsure why this happened. But they suggested it may be because hormone therapy typically causes patients to gain weight, meaning the jabs aren't able to work effectively. For these patients, 'we may need to go up to a higher dose', Professor Neil Iyengar, then an oncologist at the Memorial Sloan Kettering Cancer Centre, New York, said.
Daily Mail
14 minutes ago
- Daily Mail
Woman who spent $10K on nose job woke up to find it looking ‘smashed'
A mother-of-four who spent $10,000 on a nose job said it was left looking 'smashed' and she struggled to breathe after the operation she had in the hope of resolving respiration problems. Ashley Caselli, now 37, had underwent a revision rhinoplasty, with Dr Lindsay Sturm in January 2021, but when she woke after around three hours she was left in a state of constant worry about her nose. The Iowa native told 'It just looked smashed. It doesn't look finished. It looks like I am missing a piece of my face. My nose doesn't even have a tip any more.' Once a social mother who loved taking pictures of herself with her children, Caselli is now consumed by fear whenever she leaves the house and is always photoshopping herself in family pictures. She also said her breathing is 'much worse', and that she wakes up several times every night with a dry mouth and has to pull up her nose when she runs to get air in. She said: 'It's just no way to live. It really hurts your self-confidence; it hurts your way of thinking whenever you do things and want to take pictures with your family. 'Every day, I look in the mirror and I am saddened by it, and when people look at me, I constantly wonder, are they looking at my nose?' Caselli is one of at least eight patients to have come forward in recent months alleging harm by Sturm, who ran a clinic in Iowa until February this year. The cosmetic surgeon and otolaryngologist - a specialist in ears, nose, throat, neck and head - has also been accused of causing the death of her patient Angela Kettwig in a lawsuit, although she denies the allegation. The lawsuit is pending. Others to come forward include Christine Heintz, who paid Sturm $20,000 for a 'mommy makeover' in November 2021, which included a breast reduction and lift, abdominoplasty and liposuction. Just after the surgery, she said that a 'giant hole' opened in Heintz's right breast going back to her ribcage, with doctors saying most of the breast had died and could not be saved. She underwent further reconstructive surgery in January 2023 which resulted in her losing most of her breasts. In another case, patient AJ Gomez-Han visited Sturm in 2024 for skin removal surgery to his thighs and arms. Afterward, he developed a bacterial infection that evolved into an open bleeding sore and required six weeks in the hospital to fix. Caselli has not filed a lawsuit, however, because the procedure happened too long ago for her to file a claim under Iowa law. The doctor's clinic Sturm Cosmetic Surgery abruptly closed on February 9, and said in an email that 'due to personal, emergent medical concerns, Dr Sturm is unavailable to provide ongoing care.' The Iowa Board of Medicine charged her with professional incompetence, including failure of a physician to exercise a degree of care ordinarily exercised by the average physician, in May 2025. Sturm opted not to contest the charges and has voluntarily surrendered her license, without admitting wrongdoing. She also filed for bankruptcy in June, according to local media reports. In Caselli's case, the mother and property manager went for her first nose job with a different surgeon in 2018 to open up her airways and resolve a long-term breathing issue. The initial procedure 'wasn't terrible,' she said, but she was still having trouble breathing out of one side of her nose and felt one side also appeared 'cuppier' than the other. This led her to contact Sturm, who said she would be able to help Caselli breathe better and have a more appealing nose. In a pre-op appointment, Caselli said Sturm told her that the previous surgeon had 'removed all the cartilage' from her nose, leaving it without proper support. (It is extremely unusual for surgeons to remove all the cartilage from a patient's nose). Sturm suggested extracting some cartilage from the top of Caselli's right ear and implanting it into her nose to help with the breathing issue, Caselli said. Caselli agreed, saying she was won over by the chance to be operated on by a female surgeon and Sturm's apparent personable and kind nature. Just before the surgery in 2021, the pair prayed together for a successful procedure and a good outcome. Caselli said after the surgery she had to wear a nose bandage and splint, a plastic device placed outside the nose after surgery to support its new shape, for about two weeks but, even with the swelling from surgery, became concerned about her nose every time she removed a bandage to wash it. 'I actually voiced my concerns because I did see some issues,' she said. 'One side of my nose that I wanted changed originally, that was still the same, and the side that was a little swollen didn't look right. 'I was also concerned because in the profile view of the side of my face, it looked different, the tip of my nose was missing, well, it didn't have a tip.' She said Sturm initially told her that the appearance could be linked to the swelling from surgery but then retorted that she shouldn't ask for a perfect nose because no one's nose is perfect. 'I was shocked by that,' Caselli said. 'I told her that I am not trying to achieve the perfect nose, I just want a functioning nose that looks nice and normal, but this doesn't. It looks normal it looks very messed up. 'She tried to make me feel bad for that.' Caselli also said that at one point a hole opened up in the middle of her nose after a suture came loose following the surgery. During the procedure, Sturm was also meant to perform liposuction on the bottom of Caselli's chin, but Caselli said that this wasn't done properly, with the area she wanted removed 'still there' when she woke up from surgery. Social: Caselli said after the procedure her nose is a constant worry for her, and she edited these these images to obscure its appearance Sturm offered to do a fat transfer to Caselli's nose after the surgery, Caselli said, but she refused, and says she's now seeking help from a new surgeon. Caselli also claimed that her breathing is now 'much worse' than before, and she has to breathe through her mouth most of the time. She said she holds up the end of her nose sometimes when she runs to get air in and is also waking up throughout the night, suffering from a dry mouth and breathing issues. 'I hope revealing this helps people,' she said. 'The irony here is that she was an expert and she still messed up my nose. Everyone should know the difference between a cosmetic surgeon and a plastic surgeon. 'I am lucky, but unlucky, people go through worse things, terrible things, but they can cover their bodies. For me, I can't cover my face.'
